The changes in the basement membrane were studied in human transitional cell carcinoma of the bladder by ordinary transmission electron microscopy and through histochemical analysis of laminin (a basement membrane specific glycoprotein). In normal transitional epithelium, the basement membrane is composed of two distinct layers, i.e., an electron-lucid layer near the cell surface, called the lamina lucida, and a denser layer close to the connective tissue, called the lamina densa. Laminin was localized in the lamina lucida in contact with the basal cells. In carcinomas these structures gradually change, and this was quite obvious in an invasive one. However, the localization pattern of laminin was constant. In other words, the lamina densa changed in various ways: rupture, detachment from cells, multilayering, and thickening, etc., but laminin was always situated around carcinoma cells and separated them from the surrounding tissue. Although the meaning of these findings is not clear now, it seems that, in the light of its biological activity previously reported, laminin may be produced by carcinoma cells in their proliferation process and may assist the invasion and metastasis of carcinoma cells.

Keywords:
Laminin, Basement membrane, Bladder carcinoma
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.